IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

262
IARC MONOGRAPHS VOLUME 82
Kirk, G.D., Camus-Randon, A.-M., Mendy, M., Goedert, J.J., Merle, P., Trepo, C., Bréchot, C.,
Hainaut, P. & Montesano, R. (2000) Ser-249 p53 mutations in plasma DNA of patients with
hepatocellular carcinoma from The Gambia. J. natl Cancer Inst., 92, 148–153
Kitada, M., Taneda, M., Ohi, H., Komori, M., Itahashi, K., Nagao, M. & Kamataki, T. (1989)
Mutagenic activation of aflatoxin B 1 by P-450 HFLa in human fetal livers. Mutat. Res., 227,
53–58
Kitada, M., Taneda, M., Ohta, K., Nagashima, K., Itahashi, K. & Kamataki, T. (1990) Metabolic
activation of aflatoxin B 1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and
fetal livers. Cancer Res., 50, 2641–2645
Klich, M.A. & Pitt, J.I. (1988) Differentiation of Aspergillus flavus from A. parasiticus and other
closely related species. Trans. Br. Mycol. Soc., 91, 99–108
Klich, M.A., Mullaney, E.J., Daly, C.B. & Cary, J.W. (2000) Molecular and physiological aspects
of aflatoxin and sterigmatocystin biosynthesis by Aspergillus tamarii and A. ochraceoroseus.
Appl. microbiol. Biotechnol., 53, 605–609
Knasmüller, S., Parzefall, W., Sanyal, R., Ecker, S., Schwab, C., Uhl, M., Mersch-Sundermann,
V., Williamson, G., Hietsch, G., Langer, T., Darroudi, F. & Natarajan, A.T. (1998) Use of
metabolically competent human hepatoma cells for the detection of mutagens and antimutagens.
Mutat. Res., 402, 185–202
Knight, L.P., Primiano, T., Groopman, J.D., Kensler, T.W. & Sutter, T.R. (1999) cDNA cloning,
expression and activity of a second human aflatoxin B 1-metabolizing member of the aldoketo
reductase superfamily, AKR7A3. Carcinogenesis, 20, 1215–1223
Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Sato, C., Tsuruta, K., Maeda, Y., Koike, M.,
Tanaka, S., Nakamura, Y., Hattori, N. & Miyaki, M. (1993) Genetic changes and histopathological
grades in human hepatocellular carcinomas. Jpn. J. Cancer Res., 84, 893–899
Kress, S., Jahn, U.R., Buchmann, A., Bannasch, P. & Schwarz, M. (1992) p53 Mutations in human
hepatocellular carcinomas from Germany. Cancer Res., 52, 3220–3223
Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. & Manns, M. (1995) Low incidence of p53
mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare
event. J. Hepatol., 23, 412–419
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P.B., Daly, A., Wrighton,
S.A., Hall, S.D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom,
S., Thummel, K., Boguski, M.S. & Schuetz, E. (2001) Sequence diversity in CYP3A
promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Nature Genet., 27, 383–391
Kurtzman, C.P., Horn, B.W. & Hesseltine, C.W. (1987) Aspergillus nomius, a new aflatoxinproducing
species related to Aspergillus flavus and Aspergillus tamarii. Antonie van
Leeuwenhoek, 53, 147–158
Kussak, A., Andersson, B. & Andersson, K. (1995) Determination of aflatoxins in airborne dust
from feed factories by automated immunoaffinity column clean up and liquid chromatography.
J. Chromatogr., 708, 55–60
Lafontaine, M., Delsaut, P., Morelle, Y. & Taiclet, A. (1994) [Aflatoxins: Sampling and analysis
in animal feed production plant.] Cahiers Notes documentaires, 156, 297–305 (in French)
Lam, K.C., Yu, M.C., Leung, J.W. & Henderson, B.E. (1982) Hepatitis B virus and cigarette
smoking: Risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res., 42,
5246–5248